Efficacy and safety of pembrolizumab (pembro) alone or in combination with chemotherapy (chemo) in patients (pts) with advanced gastric or gastroesophageal (G/GEJ) cancer: Long-term follow up from KEYNOTE-059 Meeting Abstract


Authors: Wainberg, Z. A.; Yoon, H. H.; Catenacci, D. V. T.; Jalal, S. I.; Muro, K.; Garrido, M.; Golan, T.; Doi, T.; Geva, R.; Ku, G. Y.; Bleeker, J. S.; Bang, Y. J.; Hara, H.; Chung, H. C.; Wang, J. D.; Hazzard, A.; Shah, S.; Fuchs, C. S.
Abstract Title: Efficacy and safety of pembrolizumab (pembro) alone or in combination with chemotherapy (chemo) in patients (pts) with advanced gastric or gastroesophageal (G/GEJ) cancer: Long-term follow up from KEYNOTE-059
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 224s
Language: English
ACCESSION: WOS:000487345805198
DOI: 10.1200/JCO.2019.37.15_suppl.4009
PROVIDER: wos
Notes: Meeting Abstract: 4009 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Geoffrey Yuyat Ku
    230 Ku